alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 9
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                         255,891
<INT-BEARING-DEPOSITS>                         561,269
<FED-FUNDS-SOLD>                                     0
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                 17,156,361
<INVESTMENTS-CARRYING>                       1,000,351
<INVESTMENTS-MARKET>                           988,195
<LOANS>                                     33,089,726
<ALLOWANCE>                                    299,825
<TOTAL-ASSETS>                              53,226,965
<DEPOSITS>                                  43,066,580
<SHORT-TERM>                                         0
<LIABILITIES-OTHER>                            763,525
<LONG-TERM>                                          0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                     4,727,234
<OTHER-SE>                                   4,287,226
<TOTAL-LIABILITIES-AND-EQUITY>              53,226,965
<INTEREST-LOAN>                              2,417,939
<INTEREST-INVEST>                            1,338,411
<INTEREST-OTHER>                                97,707
<INTEREST-TOTAL>                             3,854,057
<INTEREST-DEPOSIT>                           2,449,190
<INTEREST-EXPENSE>                           2,449,190
<INTEREST-INCOME-NET>                        1,404,867
<LOAN-LOSSES>                                    7,500
<SECURITIES-GAINS>                             (26,932)
<EXPENSE-OTHER>                              1,847,006
<INCOME-PRETAX>                               (460,786)
<INCOME-PRE-EXTRAORDINARY>                    (460,786)
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (403,986)
<EPS-PRIMARY>                                     (.51)
<EPS-DILUTED>                                     (.51)
<YIELD-ACTUAL>                                    2.54
<LOANS-NON>                                     26,000
<LOANS-PAST>                                         0
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                               259,466
<CHARGE-OFFS>                                        0
<RECOVERIES>                                    32,859
<ALLOWANCE-CLOSE>                              299,825
<ALLOWANCE-DOMESTIC>                           299,825
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                              0
        

</TABLE>
Exhibit 3.1



CERTIFICATE OF MERGER

OF

INDEPENDENCE BANCORP

INTO

HARRODSBURG FIRST FINANCIAL BANCORP, INC.

(UNDER SECTION 252 OF THE GENERAL

CORPORATION LAW OF THE STATE OF DELAWARE)



The undersigned corporation organized and existing under
and by virtue of the General Corporation Law of the State of Delaware, DOES HEREBY CERTIFY:



FIRST: That the name and state of incorporation of each of the constituent corporations of the merger is as follows:



|                                          |  |                       
|----------------------------------------- |  | ----------------------
|Name                                      |  | State of Incorporation
|Harrodsburg First Financial Bancorp, Inc. |  | Delaware              
|Independence Bancorp                      |  | Indiana               



SECOND: That an
Agreement and Plan of Reorganization between the parties to the merger has been approved, adopted, certified, executed and acknowledged by Harrodsburg First Financial Bancorp, Inc. and Independence Bancorp in accordance with the requirements of
subsection (c) of Section 252 of the General Corporation Law of the State of Delaware.



THIRD: That the name of the surviving corporation of the merger is Harrodsburg First Financial Bancorp, Inc.



FOURTH: That the Certificate of Incorporation of Harrodsburg First Financial Bancorp, Inc. is to be amended by changing Article I so that, as
amended, said Article shall be read as follows: The name of the corporation is 1stIndependence Financial Group,
Inc. (herein the Corporation).



FIFTH: That
the surviving corporation is a corporation of the State of Delaware.



SIXTH: That the executed Agreement and Plan of Reorganization is on file at the principal place of business of the surviving corporation. The address of the principal place of business of the surviving corporation is 104 South Chiles
Street, Harrodsburg, KY 40330-1620.



SEVENTH:
That a copy of the Agreement and Plan of Reorganization will be furnished by the surviving corporation, on request and without cost, to any stockholder of Harrodsburg First Financial Bancorp, Inc. or Independence Bancorp.



EIGHTH: The authorized capital stock of Independence Bancorp is
5,000,000 shares of common stock, no par value per share.



NINETH:The merger between the aforesaid constituent corporations shall be effective on July 9, 2004 at 5:00 p.m., Eastern Time.



- 1 -



---

IN WITNESS WHEREOF, Harrodsburg First Financial Bancorp, Inc., has caused the Certificate to be
signed and attested to by its duly authorized officers this the 1st day of July, 2004.



HARRODSBURG FIRST FINANCIAL BANCORP, INC.By:

/s/ Arthur L. FreemanArthur L. FreemanChairman of the Board andChief Executive Officer




|               
|---------------
|ATTEST:        
|               
|/s/ Teresa Noel
|Teresa Noel    
|Secretary      



- 2 -
NOT FOR PUBLICATION

UNITED STATES COURT OF APPEALS

FOR THE NINTH CIRCUIT

KEICY CHUNG, 

Plaintiff-Appellant, 

 v. 

VISTANA VACATION OWNERSHIP, 

INC.; STARWOOD HOTELS AND 

RESORTS WORLDWIDE, LLC, FKA 

Starwood Hotels and Resorts Worldwide, 

Inc., 

Defendants-Appellees.

No. 17-56691 

D.C. No. 2:17-cv-04803-RGK-JC 

MEMORANDUM*

Appeal from the United States District Court

for the Central District of California

R. Gary Klausner, District Judge, Presiding

Submitted April 11, 2018**

Before: SILVERMAN, PAEZ, and OWENS, Circuit Judges.

Keicy Chung appeals pro se from the district court’s judgment dismissing 

his diversity action alleging state law claims related to his purchase of a timeshare 

 

* This disposition is not appropriate for publication and is not precedent 

except as provided by Ninth Circuit Rule 36-3.

** The panel unanimously concludes this case is suitable for decision 

without oral argument. See Fed. R. App. P. 34(a)(2).

FILED

APR 17 2018

MOLLY C. DWYER, CLERK

U.S. COURT OF APPEALS
2 17-56691 

property in Hawaii. We have jurisdiction under 28 U.S.C. § 1291. We review de 

novo a dismissal under Federal Rule of Civil Procedure 12(b)(6). Hebbe v. Pliler, 

627 F.3d 338, 341 (9th Cir. 2010). We affirm.

The district court properly dismissed Chung’s claim under California’s 

Vacation Ownership and Time-Share Act of 2004 (“VOTSA”) because the parties’

agreement expressly provides for Hawaii law to govern legal disputes regarding 

the sale, Hawaii has a substantial relationship to the transaction, and there is no 

showing that Hawaii law is contrary to a fundamental policy of California. See 

Nedlloyd Lines B.V. v. Superior Court, 834 P.2d 1148, 1151-52 (Cal. 1992)

(setting forth California’s choice-of-law framework where the parties have 

contractually agreed upon a governing law).

The district court did not abuse its discretion by dismissing Chung’s 

VOTSA claim without providing an opportunity to amend because amendment of 

this claim would have been futile. See Cervantes v. Countrywide Home Loans, 

Inc., 656 F.3d 1034, 1041 (9th Cir. 2011) (setting forth standard of review and 

stating that leave to amend may be denied where amendment would be futile).

The district court properly dismissed Chung’s fraud claim because Chung 

failed to satisfy the heightened pleading standard set forth in Federal Rule of Civil 
3 17-56691 

Procedure 9(b). See Vess v. Ciba-Geigy Corp. USA, 317 F.3d 1097, 1106 (9th 

Cir. 2003) (“Averments of fraud must be accompanied by ‘the who, what, when, 

where, and how’ of the misconduct charged.” (citation omitted)). Because Chung 

has made no attempt to clarify how he would overcome these deficiencies in his 

complaint, we conclude that the district court properly determined that leave to 

amend would be futile. See Kendall v. Visa USA, Inc., 518 F.3d 1042, 1052 (9th 

Cir. 2008) (amendment is futile where a plaintiff “fail[s] to state what additional 

facts [he] would plead if given leave to amend, or what additional discovery [he] 

would conduct to discover such facts”).

AFFIRMED.
Exhibit
15.1  
  CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRMS
  We hereby
consent to the incorporation by reference in the Registration Statement on Form
F-3 (No. 333-157796), in the Registration Statements on Form S-8 (No. 333-13570
and No. 333-106591), and into each respective prospectus that forms a part of
those Registration Statements of Deutsche Telekom AG of our reports dated
February 25, 2010 with respect to the consolidated financial statements and the
effectiveness of internal control over financial reporting of the Company
included in this Annual Report (Form 20-F) for the year ended December 31,
2009.
  
  February
25, 2010
 
 
 Ernst
      & Young GmbH
                Wirtschaftsprüfungsgesellschaft
                Stuttgart
                
                /s/Prof. Dr. Wollmert
              
              /s/
      Forst(Prof.
      Dr. Wollmert)
                Wirtschaftsprüfer
              
              (Forst)
                WirtschaftsprüferPricewaterhouseCoopers
                Aktiengesellschaft
                Wirtschaftsprüfungsgesellschaft
                Frankfurt
      am Main
                
                /s/ Prof. Dr. Kämpfer
              
              /s/ Tandetzki(Prof.
      Dr. Kämpfer)
                Wirtschaftsprüfer
              
              (Tandetzki)
                Wirtschaftsprüfer
Michigan Supreme Court

Lansing, Michigan

Robert P. Young, Jr.

, Chief Justice

Stephen J. Markman

Brian K. Zahra

Bridget M. McCormack

David F. Viviano

Richard H. Bernstein

Joan L. Larsen,

Justices

I, Larry S. Royster , Clerk of the Michigan Supreme Court, certify that the

foregoing is a true and complete copy of the order entered at the direction of the Court.

October 5, 2016

t0928 

# Order

Clerk October 5, 2016

153209

PEOPLE OF THE STATE OF MICHIGAN,

Plaintiff

- Appellee,

v SC: 153209

COA: 330148

Calhoun CC: 2015

- 000455

- FH

KEITH EDWARD WORTHINGTON,

Defendant

- Appellant.

_________________________________________/

On order of the Court, the application for leave to appeal the January 6, 2016 order

of the Court of Appeals is considered and, it appearing t o this Court that the case of

People v Comer (Docket No. 152713) is pending on appeal before this Court and that the

decision in that case may resolve an issue raised in the present application for leave to

appeal, we ORDER that the application be held in ABEYANCE pending the decision in

that case.
§ 520.1720c Phenylbutazone paste. ( a ) *Specifications.* ( 1 ) Each gram of paste contains 0.2 grams phenylbutazone.
( 2 ) Each gram of paste contains 0.35 grams phenylbutazone.
( b ) *Sponsors.* See sponsor numbers in § 510.600(c) of this chapter. ( 1 ) No. 000061 for use of product described in paragraph (a)(1) of this section.
( 2 ) No. 017030 for use of product described in paragraph (a)(2) of this section.
( c ) *Conditions of use in horses* — ( 1 ) *Amount.* 1 to 2 grams of phenylbutazone per 500 pounds of body weight, not to exceed 4 grams daily.
( 2 ) *Indications for use.* For relief of inflammatory conditions associated with the musculoskeletal system.
( 3 ) *Limitations.* Do not use in horses intended for human consumption. Federal law prohibits the use of this drug in female dairy cattle 20 months of age or older. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[45 FR 84762, Dec. 23, 1980, as amended at 58 FR 29777, May 24, 1993; 61 FR 8873, Mar. 6, 1996; 62 FR 61625, Nov. 19, 1997; 68 FR 43926, July 25, 2003; 72 FR 60550, Oct. 25, 2007; 77 FR 4897, Feb. 1, 2012; 78 FR 28826, May 20, 2014; 79 FR 74020, Dec. 15, 2014]
<PAGE>   1

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                                WASHINGTON, D.C.

                                     FORM 15

             CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
          UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR
         SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
                     OF THE SECURITIES EXCHANGE ACT OF 1934.


                                           SEC File Number :      000-15508
                                                            --------------------


                        HAWAII NATIONAL BANCSHARES, INC.
--------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)


                  45 NORTH KING STREET, HONOLULU, HAWAII 96817
--------------------------------------------------------------------------------
  (Address, including zip code, and telephone number, including area code, of
                   registrant's principal executive offices)


                         $200.00 PAR VALUE COMMON STOCK
--------------------------------------------------------------------------------
            (Title of each class of securities covered by this Form)


                                      NONE
--------------------------------------------------------------------------------
  (Titles of all other classes of securities for which a duty to file reports
                     under section 13(a) or 15(d) remains)


        Please place an X in the box(es) to designate, the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:


           Rule 12g-4(a)(1)(i)    [X]       Rule 12h-3(b)(1)(i)    [ ]
           Rule 12g-4(a)(1)(ii)   [ ]       Rule 12h-3(b)(1)(ii)   [ ]
           Rule 12g-4(a)(2)(i)    [ ]       Rule 12h-3(b)(2)(i)    [ ]
           Rule 12g-4(a)(2)(ii)   [ ]       Rule 12h-3(b)(2)(ii)   [ ]
                                  [ ]       Rule 15d-6             [ ]

        Approximate number of holders of record as of the certification or
notice date: 100


        Pursuant to the requirements of the Securities Exchange Act of 1934
Hawaii National Bancshares, Inc. has caused this certification/notice to be
signed on its behalf by the undersigned duly authorized person.



Date September 1, 1999                 By:    /s/ Ernest T. Murata
    --------------------                   -------------------------------------
                                       Ernest T. Murata, Vice President,
                                       Treasurer and Chief Financial Officer

Instruction: This form is required by Rules 12g-4, 12h-3 and 15d-6 of the
General Rules and Regulations under the Securities Exchange Act of 1934. The
registrant shall file with the Commission three copies of Form 15, one of which
shall be manually signed. It may be signed by an officer of the registrant, by
counsel or by any other duly authorized person. The name and title of the person
signing the form shall be typed or printed under the signature.
##### 



Exhibit (32)(a)

Certification of Chief Executive Officer Pursuant to 18 U.S.C. § 1350
(Section 906 of the Sarbanes-Oxley Act of 2002)

Pursuant to 18 U.S.C. § 1350, the undersigned officer of Republic Bancorp Inc.
(the Company) hereby certifies, to such officers knowledge, that the
Companys Quarterly Report on Form 10-Q for the quarter ended June 30, 2003
(the Report) fully complies with the requirements of Section 13(a) or 15(d),
as applicable, of the Securities Exchange Act of 1934 and that the information
contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.

|                       |  |                                             
|---------------------- |  | --------------------------------------------
|Dated: August 13, 2003 |  | /s/ Dana M. Cluckey
Name: Dana M. Cluckey   
|                       |  | Title: President and Chief Executive Officer

The foregoing certification accompanies the filing and is being furnished
solely pursuant to 18 U.S.C. § 1350.

A signed original of this written statement required by Section 906, or other
document authenticating, acknowledging, or otherwise adopting the signature
that appears in typed form within the electronic version of this written
statement required by Section 906, has been provided to Republic Bancorp Inc.
and will be retained by Republic Bancorp Inc. and furnished to the Securities
and Exchange Commission or its staff upon request.
§ 520.1242g Levamisole resinate and famphur paste. ( a ) *Specifications.* The drug is a paste containing 11.6 percent levamisole resinate (50 percent potency) and 23.6 percent famphur.
( b ) *Sponsor.* See 000061 in § 510.600(c) of this chapter.
( c ) *Special considerations.* Do not use any cholinesterase-inhibiting drugs, pesticides, insecticides, or chemicals on cattle simultaneously or within a few days before or after treatment with this product.
( d ) *Related tolerances.* See §§ 556.273 and 556.350 of this chapter.
( e ) *Conditions of use in cattle* — ( 1 ) *Amount.* 8 milligrams of levamisole hydrochloride (equivalent) and 30 milligrams of famphur activity per kilogram of body weight.
( 2 ) *Indications for use.* For treatment of cattle infected with the following parasites: Stomach worms (*Haemonchus, Trichostrongylus, Ostertagia*), intestinal worms (*Trichostrongylus, Cooperia, Nematodirus, Bunostomum, Oesophagostomum*), lungworms (*Dictyocaulus*), cattle grubs (*Hypoderma*), biting lice (*Bovicola*), and sucking lice (*Linognathus, Solenoptes*).
( 3 ) *Limitations.* Drug is not effective against lice eggs. Conditions of constant helminth and ectoparasitic exposure may require retreatment within 2 to 4 weeks after first treatment. Do not administer to cattle within 19 days of slaughter. Do not administer to dairy animals of breeding age. Do not use in calves less than 3 months old, or in debilitated animals. Do not treat Brahman bulls. Consult your veterinarian for assistance in the diagnosis, treatment, and control of parasitism.
[53 FR 23757, June 24, 1988, as amended at 54 FR 1353, Jan. 13, 1989; 57 FR 7652, Mar. 4, 1992; 62 FR 55160, Oct. 23, 1997; 62 FR 61625, Nov. 19, 1997; 78 FR 28823, May 20, 2014]
<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               JUN-30-1999
<CASH>                                         117,712
<SECURITIES>                                         0
<RECEIVABLES>                                    8,460
<ALLOWANCES>                                   (1,709)
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                       5,884,003
<DEPRECIATION>                             (3,556,644)
<TOTAL-ASSETS>                               3,241,797
<CURRENT-LIABILITIES>                          325,234
<BONDS>                                      2,410,376
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                     506,187
<TOTAL-LIABILITY-AND-EQUITY>                 3,241,797
<SALES>                                              0
<TOTAL-REVENUES>                             1,195,013
<CGS>                                                0
<TOTAL-COSTS>                                1,250,945
<OTHER-EXPENSES>                             (536,532)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              80,766
<INCOME-PRETAX>                                240,822
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            240,822
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   240,822
<EPS-BASIC>                                       2.80
<EPS-DILUTED>                                     2.80


</TABLE>
##### 



Exhibit 32

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF
2002


In connection with the Annual Report of Bell
Industries, Inc. (the Company), on
Form 10-K for the year ended December 31, 2003, as
filed with the Securities and Exchange Commission (the
Report), I, Tracy A. Edwards, Chief Executive
Officer and Chief Financial Officer of the Company, certify,
pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of The Sarbanes-Oxley Act of 2002,
that to the best of my knowledge and belief:



| |   |                                                                                                                                                             
| | - | ------------------------------------------------------------------------------------------------------------------------------------------------------------
| |  | The Report fully complies with the requirements
    of Section 13(a) or 15(d) of the Securities Exchange Act of
    1934; and                               
|
| |  | The information contained in the Report fairly
    presents, in all material respects, the financial condition and
    results of operations of the Company.

Dated the 26th day of March, 2004



| |                                                        
| | -------------------------------------------------------
| | /s/ TRACY A. EDWARDS                                   
|
| | Tracy A. Edwards                                       
| | Chief Executive Officer and Chief Financial
    Officer
AdivrsionortheAmericanChemicalSocietyPhone:800-631-1884,614-447-3870Fax: 614-447-3747E-mail:answers@cas.orgWeb:www.cas.org/productslother-cas-products/client-services/INVENTORYEXPERTSERVICEREPORTIESOrderNumber:378304RegistryNumber:CAIndexName:CASPleaseprinttheaboveCAIndexNameontheappropriatepageofyourPMN.Ifthisboxischecked,CAShasmadecorrection(s)marked inredtoyourIESorder.PleasemakethesamecorrectionstoyourPMNbeforesubmittingittotheEPA.2540OlentangyRiverRoadP.O.Box3343Columbus,OH43210-0334USA